In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Isabelle C Van Gelder
Speaker
Isabelle C Van Gelder
Isabelle C Van Gelder Isabelle C Van Gelder

University Medical Center Groningen, Groningen (Netherlands (The))

Specialities : Atrial Fibrillation , Arrhythmias-General, Stroke

Isabelle C. Van Gelder obtained her MD PhD in Groningen, the Netherlands. Since 1995 she is working as cardiologist at the University Medical Center Groningen. Since 2006 she is Professor of Cardiology at the University of Groningen. She is Board member of EHRA and chair of the EHRA programme committee 2020-2022 and a visiting professor of the University of Southern Denmark, Odense, Denmark. She was awarded with the ESC silver medal for her work in Clinical Cardiology and gave the ESC 2019 René Laënnec lecture. She is PI of >20 trials including RACE trials and STEEER AF. She is Task Force member of the ESC AF 2020 Guidelines and Associate Editor of Europace and Heart. Her research focuses on understanding the susceptibility to AF and it adverse outcomes including AF progression. It explores novel management strategies to prevent adverse outcomes with a focus on cardiovascular risk management.

32 presentations from this speaker

2020 ESC Guidelines on Atrial Fibrillation - Live.

Event : ESC Congress 2020

  • Session : 2020 ESC Guidelines on Atrial Fibrillation - Live
  • Speaker : G Hindricks (Leipzig,DE), IC Van Gelder (Groningen,NL), G Boriani (Castenaso-Bo,IT), GYH Lip (Liverpool,GB), C Blomstrom-Lundqvist (Uppsala,SE), E Arbelo (Barcelona,ES), TS Potpara (Belgrade,RS)

Co-morbidity control: impact on AF prevention and AF burden.

Event : ESC Congress 2020

  • Session : 2020 ESC Guidelines on Atrial Fibrillation
  • Speaker : IC Van Gelder (Groningen,NL)

Daily Wrap Up Saturday.

Event : ESC Congress 2020

  • Session : Daily Wrap-Up Saturday
  • Speaker : G Hindricks (Leipzig,DE), IC Van Gelder (Groningen,NL), S Priori (Pavia,IT)

Hot Line BRACE CORONA.

Event : ESC Congress 2020

  • Session : Hot Line BRACE CORONA
  • Speaker : IC Van Gelder (Groningen,NL), G Hindricks (Leipzig,DE), R Lopes (Durham,US), G Parati (Milano,IT)

Hot Line IMPACT-Afib.

Event : ESC Congress 2020

  • Session : Hot Line IMPACT-Afib
  • Speaker : IC Van Gelder (Groningen,NL), G Hindricks (Leipzig,DE), SD Pokorney (Durham,US), C Leclercq (Rennes,FR)

Application of new implantable cardiac monitoring devices for the management of cryptogenic stroke.

Event : EHRA 2019

  • Session : New frontiers in diagnosis: implantable cardiac monitors
  • Speaker : IC Van Gelder (Groningen,NL)
  • Sponsored by Abbott

Arrhythmia interventions in acute heart failure.

Event : ESC Congress 2019

  • Session : Cutting edge heart failure treatment
  • Speaker : IC Van Gelder (Groningen,NL)

Atrial fibrillation and heart failure - Current knowledge

Event : EHRA 2019

  • Session : Atrial fibrillation and heart failure
  • Speaker : IC Van Gelder (Groningen,NL)
  • Joint session with the Heart Failure Association of the ESC

Atrial fibrillation: not just an arrhythmia

Event : ESC Congress 2019

  • Session : ESC Rene Laennec Lecture on Clinical Cardiology
  • Speaker : IC Van Gelder (Groningen,NL)

CABANA will affect my clinical decision making in atrial fibrillation ablation - CONTRA

Event : EHRA 2019

  • Session : Controversies in atrial fibrillation ablation
  • Speaker : IC Van Gelder (Groningen,NL)

Clinical atrial fibrillation

Event : EHRA 2019

  • Session : EHRA 2019 - Congress highlights
  • Speaker : IC Van Gelder (Groningen,NL)

Practical tips to optimise stroke prevention with NOACs

Event : ESC Congress 2019

  • Session : Practical tips to optimise stroke prevention with non-vitamin K antagonist oral anticoagulants (NOACs)
  • Speaker : TS Potpara (Belgrade,RS), I Savelieva (London,GB), IC Van Gelder (Groningen,NL)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

The best from science and education - Atrial fibrillation

Event : EHRA 2019

  • Session : Science and insights from a top arrhythmias journal – News from EP-Europace
  • Speaker : IC Van Gelder (Groningen,NL)

Atrial fibrillation in heart failure - Current knowledge

Event : ESC Congress 2018

  • Session : Atrial fibrillation in heart failure
  • Speaker : IC Van Gelder (Groningen,NL)

Characteristics and outcomes of atrial fibrillation in patients without conventional risk factors: A RE-LY AF registry analysis

Event : EHRA 2018

  • Session : Mechanisms and outcomes in atrial fibrillation
  • Speaker : IC Van Gelder (Groningen,NL)

Clinical atrial fibrillation

Event : EHRA 2018

  • Session : EHRA 2018 Congress Highlights
  • Speaker : IC Van Gelder (Groningen,NL)

Critical appraisal of the CABANA and CASTLE-AF trials.

Event : ESC Congress 2018

  • Session : Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?
  • Speaker : IC Van Gelder (Groningen,NL)
  • European Heart Rhythm Association (EHRA)

Paroxysmal atrial fibrillation - A cause or mere marker of cardioembolic risk?

Event : ESC Congress 2018

  • Session : Stroke, atrial fibrillation and anticoagulation
  • Speaker : IC Van Gelder (Groningen,NL)

Risk factor management and upstream therapy in AF - Does it improve outcome?

Event : EHRA 2018

  • Session : Integrated care of patients with atrial fibrillation
  • Speaker : IC Van Gelder (Groningen,NL)

The way forward for education of practicing cardiologists & HCPs (blended learning, performance and quality improvement educational programmes).

Event : ESC Congress 2018

  • Session : The changing environment of Cardiology Education and Training: ESC and UEMS Cardiac Section - We can do it together
  • Speaker : IC Van Gelder (Groningen,NL)

A monitoring and triaging center: what are the benefits for pacemaker patients?

Event : EHRA 2017

  • Session : Latest developments in pacemaker therapy
  • Speaker : IC Van Gelder (Groningen,NL)
  • Sponsored by Medtronic

Lone atrial fibrillation does not exist!

Event : ESC Congress 2017

  • Session : Atrial fibrillation or left atrial disease?
  • Speaker : IC Van Gelder (Groningen,NL)

Rate control

Event : ESC Congress 2016

  • Session : Atrial fibrillation
  • Speaker : IC Van Gelder (Groningen,NL)
  • Joint with the Lancet

State of the art in bleeding risk in atrial fibrillation.

Event : ESC Congress 2016

  • Session : Are you still afraid about bleeding risk of antithrombotic therapy in atrial fibrillation?
  • Speaker : IC Van Gelder (Groningen,NL)

My patient has a CHA2DS2-VASc score 1 - Do I have to anticoagulate? Conclusion and take home message.

Event : ESC Congress 2015

  • Session : Stroke and risk in atrial fibrillation: what do the Guidelines say?
  • Speaker : IC Van Gelder (Groningen,NL)

New antiarrhythmic drugs - will they really replace the old one's

Event : EHRA 2015

  • Session : Antiarrhythmic drugs for prevention of atrial fibrillation - what is new?
  • Speaker : IC Van Gelder (Groningen,NL)

AF and heart failure: a question of management?

Event : ESC Congress 2014

  • Session : Closing the mortality gap in atrial fibrillation
  • Speaker : IC Van Gelder (Groningen,NL)

How important is strict rate control?

Event : ESC Congress 2013

  • Session : Controversies in atrial fibrillation
  • Speaker : IC Van Gelder (Groningen,NL)

Panel.

Event : ESC Congress 2013

  • Session : Atrial fibrillation: burning issues, ablation and answers to your questions
  • Speaker : C de Chillou (Vandoeuvre Les Nancy,FR), H Kottkamp (Duesseldorf,DE), H Puererfellner (Linz,AT), A Raviele (Mestre,IT), R Schilling (London,GB), IC Van Gelder (Groningen,NL)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are